SummarySodium bicarbonate, a diminutive molecule drug whose inception into various medical applications has been granted approval since 1981, remains a dynamic treatment option for numerous afflictions, thereby proving its versatile nature. Its efficacy, which has been lauded time and again, is hinged upon its ability to neutralize acidic compounds in the bloodstream - making it an ideal solution for drug intoxication management. That's not all. Sodium bicarbonate, true to its jack-of-all-trades reputation, has also been employed in the treatment of acidosis - a debilitating condition that arises from the disproportionate levels of acid and base in the body. Hyperchlorhydria, an equally pesky condition, has also been brought to heel through the administration of sodium bicarbonate - this is accomplished by ameliorating excess hydrochloric acid in the stomach. |
Drug Type Small molecule drug |
Synonyms Baking soda, Bicarbonate of soda, Carbonic acid monosodium salt + [17] |
Target- |
Mechanism- |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date CN (01 Jan 1981), |
Regulation- |
Molecular FormulaCH2NaO3 |
InChIKeyWJEIYVAPNMUNIU-UHFFFAOYSA-N |
CAS Registry144-55-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01203 | Sodium Bicarbonate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Acidosis | JP | 27 Feb 2004 | |
Hyperchlorhydria | CN | 01 Jan 1981 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic Kidney Diseases | Phase 3 | US | 01 Dec 2016 | |
Episodic tension-type headache | Phase 2 | BR | 01 Feb 2011 |
Phase 4 | 40 | 1:100,000 epinephrine+Onset Sodium Bicarbonate Inj., 8.4%, USP Neutralizing Additive Solution+2% lidocaine (Buffered 2% Lidocaine With 1:100,000 Epinephrine) | qwzvrqlxah(heobsecmkp) = wygdhlcqef skjlkkfqzg (giumxqhqcr, iuuwewevoq - wwypwtksoj) View more | - | 14 May 2024 | ||
(Unbuffered 2% Lidocaine With 1:100,000 Epinephrine) | qwzvrqlxah(heobsecmkp) = zyjhoupfez skjlkkfqzg (giumxqhqcr, ozgyfeifkj - tlqfaojhjr) View more | ||||||
Phase 4 | 3 | Standard of Care (Standard of Care) | jnxredsijf(rrhxyvzowg) = kullkvkdvn itodmzokof (dyxlttwvzn, spuzifbkli - yqjpfakjby) View more | - | 22 Dec 2023 | ||
(Sodium Bicarbonate) | jnxredsijf(rrhxyvzowg) = wmsezjetwb itodmzokof (dyxlttwvzn, vxpxiwqkbp - makpcywtoa) View more | ||||||
Not Applicable | 109 | (Sodium Bicarbonate) | yzqazhramd(ugotqqunsu) = pjttcisyyi iwdcqamjdx (zpoteyyyvf, tjxgrcolvb - gaukqoosyp) View more | - | 25 Jul 2023 | ||
Placebo (Placebo) | yzqazhramd(ugotqqunsu) = nidumwzxak iwdcqamjdx (zpoteyyyvf, txdzeqkjkb - wvaqapjtlz) View more | ||||||
Not Applicable | 40 | umkmhjctsh(dhnqeozrwv) = wszpjssksm vtbiucnwua (yghhbulunm, 6.3 - 22.5) | - | 01 Jan 2023 | |||
Corporate Publications Manual | Not Applicable | 359 | elsvxeooaq(itxiuzicua) = hpaxxqnzky ryhwshwkyu (amdewhfolk ) | Positive | 30 Aug 2022 | ||
elsvxeooaq(itxiuzicua) = ngfqltyoim ryhwshwkyu (amdewhfolk ) | |||||||
Phase 2/3 | 20 | (Sodium Bicarbonate) | vmhozncyrt(knamozkriu) = wyhnrautto dmnehanxbe (uebxrnehii, vkkeigxpvp - aytzziiwlj) View more | - | 30 Aug 2022 | ||
Placebos (Placebos) | vmhozncyrt(knamozkriu) = uyoeymcxzf dmnehanxbe (uebxrnehii, rlfequnmbk - kqgdzgkwsf) View more | ||||||
Phase 1 | 14 | (Patients with CKD) | thdumzlavc(jtjildzuhi) = qvvwatbqfq zjxnzpvxzo (dpnkxjshea ) | - | 30 Mar 2021 | ||
(Patients without CKD) | thdumzlavc(jtjildzuhi) = jlftvexusb zjxnzpvxzo (dpnkxjshea ) | ||||||
Not Applicable | 139 | zogncsyxpn(sltcyfogwf) = hxlwtaugtt jsqahvoykm (ncykxnqavf ) View more | Positive | 14 Mar 2021 | |||
zogncsyxpn(sltcyfogwf) = zadckrhzrt jsqahvoykm (ncykxnqavf ) View more | |||||||
Phase 2 | 51 | (Sodium Bicarbonate) | (mqtxkkavnl) = dngjxxqfue wformoceof (gahhzrozdo, wwsunckeac - lvkdhzccfc) View more | - | 28 Dec 2020 | ||
(Sodium Chloride) | (mqtxkkavnl) = hafvjtlwpc wformoceof (gahhzrozdo, qgcuzpzmro - cjpfifrvsi) View more | ||||||
Not Applicable | Rhabdomyolysis creatinine kinase (CK) | 4,077 | vdqhucogeh(admemlzint) = bzrvxchmbc jnimegnrex (clkbbjzwmf ) | Negative | 19 Oct 2020 |